Tomomi Komura, Masayuki Yoshida, Rio Kurihara, Masato Kinoshita, Masaru Yoshida, Yoshikazu Nishikawa
bioRxiv 2025年1月18日 筆頭著者責任著者
In Parkinson's disease (PD), α–synuclein (αSyn) accumulation drives neuropathological progression, establishing it as a potential therapeutic target. Lactic acid bacteria (LAB) provide various health benefits to the host and are expected to offer protective effects on neurological functions through the brain–gut connection, as indicated by animal studies. However, the protective effects of LAB against αSyn are not well understood. We investigated whether LAB feeding could reduce αSyn accumulation and improve mobility in transgenicCaenorhabditis elegans, an invertebrate model organism that expresses human αSyn in muscle. Among the nine screened strains,Pediococcus pentosaceussuppressed αSyn accumulation and the decrease in bending counts, a locomotion index in nematodes. Additionally, feedingP. pentosaceustoOryzias latipes(medaka), a vertebrate model organism, alleviated PD–like behavioral defects induced by 1–methyl–4–phenyl–1,2,3,6–tetrahydropyridine.P. pentosaseusacts as a probiotic against PD, and PD model worms and medaka can be used to screen effective LAB for prevention.